297 related articles for article (PubMed ID: 15911097)
21. Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4.
Yousef GM; Luo LY; Diamandis EP
Anticancer Res; 1999; 19(4B):2843-52. PubMed ID: 10652563
[TBL] [Abstract][Full Text] [Related]
22. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
Dorn J; Harbeck N; Kates R; Magdolen V; Grass L; Soosaipillai A; Schmalfeldt B; Diamandis EP; Schmitt M
Biol Chem; 2006 Aug; 387(8):1121-8. PubMed ID: 16895483
[TBL] [Abstract][Full Text] [Related]
23. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender.
Komatsu N; Saijoh K; Sidiropoulos M; Tsai B; Levesque MA; Elliott MB; Takehara K; Diamandis EP
J Invest Dermatol; 2005 Dec; 125(6):1182-9. PubMed ID: 16354188
[TBL] [Abstract][Full Text] [Related]
24. Human tissue kallikreins: physiologic roles and applications in cancer.
Borgoño CA; Michael IP; Diamandis EP
Mol Cancer Res; 2004 May; 2(5):257-80. PubMed ID: 15192120
[TBL] [Abstract][Full Text] [Related]
25. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
26. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Zheng Y; Katsaros D; Shan SJ; de la Longrais IR; Porpiglia M; Scorilas A; Kim NW; Wolfert RL; Simon I; Li L; Feng Z; Diamandis EP
Clin Cancer Res; 2007 Dec; 13(23):6984-92. PubMed ID: 18056174
[TBL] [Abstract][Full Text] [Related]
27. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
Luo LY; Jiang W
Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
[TBL] [Abstract][Full Text] [Related]
28. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP
Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772
[TBL] [Abstract][Full Text] [Related]
29. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
[TBL] [Abstract][Full Text] [Related]
30. Human tissue kallikreins: a new enzymatic cascade pathway?
Yousef GM; Diamandis EP
Biol Chem; 2002; 383(7-8):1045-57. PubMed ID: 12437087
[TBL] [Abstract][Full Text] [Related]
31. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
32. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
[TBL] [Abstract][Full Text] [Related]
34. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP
Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734
[TBL] [Abstract][Full Text] [Related]
35. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.
Debela M; Magdolen V; Schechter N; Valachova M; Lottspeich F; Craik CS; Choe Y; Bode W; Goettig P
J Biol Chem; 2006 Sep; 281(35):25678-88. PubMed ID: 16740631
[TBL] [Abstract][Full Text] [Related]
36. Human kallikrein 13 involvement in extracellular matrix degradation.
Kapadia C; Ghosh MC; Grass L; Diamandis EP
Biochem Biophys Res Commun; 2004 Oct; 323(3):1084-90. PubMed ID: 15381110
[TBL] [Abstract][Full Text] [Related]
37. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
Lawrence MG; Lai J; Clements JA
Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
[TBL] [Abstract][Full Text] [Related]
38. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.
Chang A; Yousef GM; Jung K; Rajpert-De Meyts E; Diamandis EP
Anticancer Res; 2001; 21(5):3147-52. PubMed ID: 11848466
[TBL] [Abstract][Full Text] [Related]
39. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA
Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]